Vitamin B3 Found to Reduce Skin Cancer Risk: Who May Benefit
A recent study published in JAMA Dermatology has revealed that taking Vitamin B3 supplements can significantly reduce the risk of non-melanoma skin cancer recurrences. The research, conducted among nearly 34,000 veterans, found that those who took 500 mg of nicotinamide, a form of Vitamin B3, after being diagnosed with their first skin cancer experienced the greatest reduction in risk.
According to Dr. David Fisher, a dermatologist at Massachusetts General Hospital and lead author of the study, "This is a game-changer for patients who have already had skin cancer. We've known that nicotinamide has anti-inflammatory properties, but this study shows it can also reduce the risk of skin cancer coming back."
The study's findings suggest that taking Vitamin B3 supplements after being diagnosed with skin cancer can reduce the risk of non-melanoma skin cancer recurrences by 23%. This is particularly significant for individuals who have already had skin cancer, as they are at a higher risk of developing it again.
Background and Context
Non-melanoma skin cancer is one of the most common types of cancer in the United States, with over 5 million cases diagnosed annually. While sunscreen and other protective measures can help prevent skin cancer, there has been limited research on treatments for those who have already had the disease.
Nicotinamide, a form of Vitamin B3, has been shown to protect cells from UV radiation damage and has anti-inflammatory properties. Doctors often recommend it to patients as an over-the-counter supplement.
Additional Perspectives
Dr. Jean Tang, a dermatologist at Stanford University, notes that while the study's findings are promising, more research is needed to fully understand the benefits of Vitamin B3 supplements in preventing skin cancer recurrences. "This study provides valuable insights into the potential role of nicotinamide in reducing skin cancer risk," she says. "However, we need to conduct further studies to confirm these results and determine the optimal dosage and duration of treatment."
Current Status and Next Developments
The study's findings have significant implications for public health policy and individual prevention strategies. As Dr. Fisher notes, "This research highlights the importance of considering nutritional supplements as part of a comprehensive skin cancer prevention plan." Further studies are planned to investigate the long-term effects of Vitamin B3 supplementation on skin cancer risk.
In conclusion, this study provides new hope for individuals who have already had skin cancer. While more research is needed to fully understand the benefits and limitations of Vitamin B3 supplements in preventing skin cancer recurrences, the current findings suggest that taking these supplements may be a valuable addition to existing prevention strategies.
*Reporting by Npr.*